STOCK TITAN
  1. Home
  2. News
  3. LH

Laboratory Corp. Of America Holdings - LH STOCK NEWS

Welcome to our dedicated news page for Laboratory Of America Holdings (Ticker: LH), a resource for investors and traders seeking the latest updates and insights on Laboratory Of America Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Laboratory Of America Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Laboratory Of America Holdings's position in the market.

News
Labcorp Announces 2023 Third Quarter Results
Rhea-AI Summary
Labcorp updates full-year guidance after reporting 6.6% revenue growth in Q3. Advanced hospital and health systems strategy through new agreements. Launches new test for Alzheimer's disease diagnosis.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.16%
Tags
earnings
-
News
Labcorp Declares Quarterly Dividend
Rhea-AI Summary
Labcorp declares cash dividend of $0.72 per share of common stock
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.01%
Tags
dividends
-
News
Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease
Rhea-AI Summary
Labcorp launches blood-based test for Alzheimer's disease detection
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.33%
Tags
none
News
LABCORP AND BAYSTATE HEALTH ANNOUNCE STRATEGIC RELATIONSHIP FOR DIAGNOSTIC LABORATORY SERVICES
Rhea-AI Summary
Labcorp to acquire Baystate Health's outreach laboratory business and select operating assets
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
none
-
News
Labcorp to Announce Third Quarter Financial Results on October 26, 2023
Rhea-AI Summary
Labcorp will release its financial results for Q3 2023 on October 26, 2023. Conference call and webcast to discuss the results will be held at 9 a.m. ET. Webcast recording will be available until October 12, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
earnings
-
News
Graves Gilbert, Circuit Clinical, and Labcorp Join Forces to Bring Clinical Trials to Patients across South Central Kentucky
Rhea-AI Summary
Graves Gilbert collaborates with Circuit Clinical to bring clinical trials to patients in Kentucky, supported by Labcorp. The partnership aims to improve patient outcomes and provide greater access to innovative medical research. Patients may participate in hybrid care options and receive extra care visits without co-pays. This collaboration demonstrates a commitment to diverse and medically underserved communities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
clinical trial
News
Labcorp to Present Strategy, Business and Financial Outlook at Investor Day
Rhea-AI Summary
Labcorp hosts Investor Day to share growth strategy and value proposition
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.43%
Tags
conferences
-
News
Labcorp Forges Strategic Partnership with Tufts Medicine, Will Acquire Outreach Laboratory Business
Rhea-AI Summary
Labcorp has announced an agreement with Tufts Medicine to acquire the Tufts Medicine outreach laboratory business and select operating assets. This partnership aims to improve access to testing, reduce wait-times for patients, and provide standardized laboratory testing throughout the Tufts Medicine system. The transaction is expected to be finalized in October 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.15%
Tags
partnership acquisition
-
News
Labcorp to Host Investor Day on September 14, 2023
Rhea-AI Summary
Labcorp (NYSE: LH) will host an Investor Day on September 14, 2023, in New York City. The event will feature Labcorp's go-forward strategy, business overviews, and a longer-term financial outlook. A live webcast will be available on Labcorp's Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.33%
Tags
conferences
News
Labcorp Announces 2023 Second Quarter Results
Rhea-AI Summary
Labcorp (NYSE: LH) announced second quarter results and full-year 2023 guidance. Second quarter revenue grew 4% versus last year, with Adjusted EPS at $3.42 versus $4.04. Full-Year 2023 Guidance includes Adjusted EPS of $13.00 to $14.00 and Free Cash Flow of $0.8 billion to $1.0 billion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.27%
Tags
earnings
Stock LH logo
Laboratory Corp. Of America Holdings

NYSE:LH

LH Rankings

#584 Ranked by Market Cap
#1736 Ranked by Stock Gains
#1633 Ranked by Dividends

LH Stock Data

17.31B
83.67M
0.34%
98.27%
2.29%
Diagnostic Imaging Centers
Health Care and Social Assistance
Link
US
Burlington

About LH

recognized for our innovation, quality, and customer convenience, labcorp delivers timely, accurate results for improved patient care. with scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, labcorp performs more than one million tests on approximately 400,000 samples each day. labcorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. labcorp operates a sophisticated laboratory network, with corporate headquarters in burlington, nc, and more than 34,000 employees worldwide. our more than 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. laboratory corporation of america holdings is listed on the new york stock exchange (nyse) under ticker symbol lh.